| |
 | |  |
|
| |
|
Pancreas cancer drug failure clue
(22/May/2009)
|
|
Experts believe they have discovered why pancreatic cancer can be so resistant to drug treatment. (Source: BBC News | Health | UK Edition)
|
|
|
|
AlphaVax Announces Full Enrollment In Phase I/II Study Of Active Immunotherapy In Patients With Advanced Or Metastatic Cancer
(20/May/2009)
|
|
RESEARCH TRIANGLE PARK, N.C. -- AlphaVax announced today the completion of enrollment in a Phase I/II CEA cancer immunotherapy study being conducted by the Duke University Comprehensive Cancer Center, Durham, NC. This Phase I/II study is an open-label, dose-escalation study to evaluate the safety and immunogenicity of carcinoembryonic antigen (CEA(6D))-expressing virus-like replicon particle (VRP) immunotherapy in patients with advanced or metastatic CEA-expressing malignancies. CEA is tumor protein found on many types of cancer including colorectal, pancreatic,
|
|
|
|
Multivitamins May Help Women Live Longer: Study
(20/May/2009)
|
|
LOS ANGELES -- Multivitamins might prolong life for women by preventing parts of their DNA from shortening, a new study has found. Researchers at the U.S. National Institute of Environmental Health Sciences (NIEHS) analyzed data on 586 women participating in the Sisters Study, which included women who had breast cancer and their cancer-free siblings, according to the HealthDay News on Monday. As part of that study, the women were asked about their use of vitamin supplements
|
|
|
|
Heavy Drinking Can Raise Risk of Pancreatic Cancer
(20/May/2009)
|
|
Long-term heavy drinkers were 1.6 times more likely to develop pancreatic cancer than nondrinkers, according to researchers at Maastricht University in the Netherlands. (Source: Alcohol, Tobacco and Other Drugs News)
|
|
|
|
Type Of Connection Procedure After Pancreatic Surgery Influenced Rate Of Pancreatic Fistula
(19/May/2009)
|
|
After surgery to remove the head of the pancreas, invagination of the pancreas into the small intestine resulted in a lower rate of pancreatic fistula, according to researchers at the Jefferson Pancreas, Biliary and Related Cancer Center. The research was published in the Journal of the American College of Surgeons. It was performed as a randomized trial the gold standard for studies. Removing the head of the pancreas, a procedure called pancreaticoduodenectomy (PD), is a common
|
|
|
|
Dialing Up The Degrees To Fight Cancer
(16/May/2009)
|
|
"My wish is simple, but I wouldn't have given it a second thought this time last year," Joe Castelli said as his eyes welled up with tears. "I want to see my children grow up. I have two daughters who are nine and seven." This longing began soon after he felt pain on his left side last summer. After taking Ibuprofen for a couple of weeks, his physician did a CAT scan. (Source: Health News
|
|
|
|
Molecular Insight Pharmaceuticals, Inc. Receives European Medicines Agency Approval To Proceed With Phase 3 Development Of OnaltaTM
(15/May/2009)
|
|
Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced that the European Medicines Agency (EMEA) has approved its Phase 3 protocol for Onalta (Yttrium-90 edotreotide). (Source: Health News from Medical News Today)
|
|
|
|
GenWay Biotech obtains exclusive rights to AMDL's DR-70 cancer test in US and Canada
(15/May/2009)
|
|
(GenWay Biotech) International studies have linked the DR-70 cancer test to at least 14 different types of cancer, including lung, breast, stomach, liver, colon, rectal, ovarian, esophageal, cervical, trophoblastic, thyroid, malignant lymphoma, brain and pancreatic cancer making it one of the most versatile cancer biomarkers available. (Source: EurekAlert! - Cancer)
|
|
|
|
MiR-196a Promotes The Metastases Of Tumors
(14/May/2009)
|
|
MicroRNAs are small RNA molecules of 20-25 nucleotides length, regulating gene expression by inhibition of transcription or translation of proteins. High levels of miR-196a, a microRNA suppressing the expression of specific homebox genes that are of high relevance for the development of the human embryo, activated oncogenic pathways inside human tumor cells and induced tumor cell dissemination. (Source: Health News from Medical News Today)
|
|
|
|
Researchers Focus On Targeted Radiation For Pancreatic Cancer Tumors
(14/May/2009)
|
|
According to the American Cancer Society, pancreatic cancer is the fourth leading cancer killer in the country, with more than 42,000 new cases expected to be diagnosed this year and more than 35,000 deaths. In New Jersey alone, 1,000 deaths are estimated from the disease, which only has a five-year, five-percent survival rate. (Source: Health News from Medical News Today)
|
|
|
| |
| | |
|